Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc H Scheetz

Showing results (101-110 of 222) with videos related to

Pageof 23
Sort By:
Critical Care Explorations|June 17, 2021
Setting the Beta-Lactam Therapeutic Range for Critically Ill Patients: Is There a Floor or Even a Ceiling?Erin F Barreto, Andrew J Webb, Gwendolyn M Pais, et al.
The Journal of Urology|June 4, 2013
Characterization of ciprofloxacin resistant Escherichia coli isolates among men undergoing evaluation for transrectal ultrasound guided prostate biopsyChao Qi, Michael Malczynski, Anthony J Schaeffer, et al.
Clinical Therapeutics|February 7, 2021
A Critical Appraisal of the Effects of Anesthetics on Immune-system Modulation in Critically Ill Patients With COVID-19Athanasios Chalkias, Erin F Barreto, Eleni Laou, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 23, 2017
Eight unexpected cases of vancomycin associated acute kidney injury with contemporary dosingJ Nicholas O'Donnell, Cybele Ghossein, Nathaniel J Rhodes, et al.
Antibiotics (Basel, Switzerland)|March 27, 2019
A Review of the Clinical Pharmacokinetics of Polymyxin BSean N Avedissian, Jiajun Liu, Nathaniel J Rhodes, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 22, 2005
Effect of on-call infectious-diseases pharmacists on antibiotic expendituresMarc H Scheetz, Michael J Postelnick, Kimberly K Scarsi, et al.
Journal of Global Antimicrobial Resistance|March 23, 2020
Clinical pharmacokinetics of ceftolozane and tazobactam in an obese patient receiving continuous venovenous haemodiafiltration: A patient case and literature reviewAhmed Mahmoud, Anooj Shah, Kaitlin Nutley, et al.
Drug Discovery Today|October 22, 2020
Novel approaches for the treatment of methicillin-resistant Staphylococcus aureus: Using nanoparticles to overcome multidrug resistanceKushal Vanamala, Katyayani Tatiparti, Ketki Bhise, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 22, 2022
Nephrotoxin Stewardship Alongside Antimicrobial StewardshipMarc H Scheetz, Jack Chang, Erin F Barreto, et al.
Clinical Therapeutics|January 4, 2011
Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort studyChristopher W Crank, Marc H Scheetz, Benjamin Brielmaier, et al.
Pageof 23

Showing results (101-110 of 222) with videos related to

Sort By:
Pageof 23
Critical Care Explorations|June 17, 2021
Setting the Beta-Lactam Therapeutic Range for Critically Ill Patients: Is There a Floor or Even a Ceiling?Erin F Barreto, Andrew J Webb, Gwendolyn M Pais, et al.
The Journal of Urology|June 4, 2013
Characterization of ciprofloxacin resistant Escherichia coli isolates among men undergoing evaluation for transrectal ultrasound guided prostate biopsyChao Qi, Michael Malczynski, Anthony J Schaeffer, et al.
Clinical Therapeutics|February 7, 2021
A Critical Appraisal of the Effects of Anesthetics on Immune-system Modulation in Critically Ill Patients With COVID-19Athanasios Chalkias, Erin F Barreto, Eleni Laou, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|January 23, 2017
Eight unexpected cases of vancomycin associated acute kidney injury with contemporary dosingJ Nicholas O'Donnell, Cybele Ghossein, Nathaniel J Rhodes, et al.
Antibiotics (Basel, Switzerland)|March 27, 2019
A Review of the Clinical Pharmacokinetics of Polymyxin BSean N Avedissian, Jiajun Liu, Nathaniel J Rhodes, et al.
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|September 22, 2005
Effect of on-call infectious-diseases pharmacists on antibiotic expendituresMarc H Scheetz, Michael J Postelnick, Kimberly K Scarsi, et al.
Journal of Global Antimicrobial Resistance|March 23, 2020
Clinical pharmacokinetics of ceftolozane and tazobactam in an obese patient receiving continuous venovenous haemodiafiltration: A patient case and literature reviewAhmed Mahmoud, Anooj Shah, Kaitlin Nutley, et al.
Drug Discovery Today|October 22, 2020
Novel approaches for the treatment of methicillin-resistant Staphylococcus aureus: Using nanoparticles to overcome multidrug resistanceKushal Vanamala, Katyayani Tatiparti, Ketki Bhise, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 22, 2022
Nephrotoxin Stewardship Alongside Antimicrobial StewardshipMarc H Scheetz, Jack Chang, Erin F Barreto, et al.
Clinical Therapeutics|January 4, 2011
Comparison of outcomes from daptomycin or linezolid treatment for vancomycin-resistant enterococcal bloodstream infection: A retrospective, multicenter, cohort studyChristopher W Crank, Marc H Scheetz, Benjamin Brielmaier, et al.
Pageof 23